Respiratory syncytial virus infection and risk of acute myocardial infarction

American Journal of the Medical Sciences

Volumn 340, Issue 5, 2010, Pages 356-359

  Guan, Xiu Ru ^a   Jiang, Li Xin ^a   Ma, Xue Hua ^a   Wang, Lan Feng ^a   Quan, Hude ^b   Li, Hong Yuan ^c  

^a THE FIRST AFFILIATED HOSPITAL OF HARBIN MEDICAL UNIVERSITY   (China)

^b UNIVERSITY OF CALGARY   (Canada)

^c HARBIN MEDICAL UNIVERSITY   (China)

Author keywords

Acute myocardial infarction; Infection; Respiratory syncytial virus

Indexed keywords

C REACTIVE PROTEIN; CHOLESTEROL; GLUCOSE; IMMUNOGLOBULIN G; TRIACYLGLYCEROL;

ACUTE HEART INFARCTION; ADENOVIRUS; ADULT; ARTICLE; BLOOD LEVEL; CHLAMYDOPHILA PNEUMONIAE; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; CYTOMEGALOVIRUS; DIET RESTRICTION; FEMALE; GLUCOSE BLOOD LEVEL; HELICOBACTER PYLORI; HERPES SIMPLEX VIRUS 1; HERPES SIMPLEX VIRUS 2; HUMAN; MAJOR CLINICAL STUDY; MALE; NONHUMAN; QUESTIONNAIRE; RESPIRATORY SYNCYTIAL PNEUMOVIRUS; RESPIRATORY SYNCYTIAL VIRUS INFECTION; RISK FACTOR; RUBELLA VIRUS; TRIACYLGLYCEROL BLOOD LEVEL;

EID: 78349306785     PISSN: 00029629     EISSN: None     Source Type: Journal    
DOI: 10.1097/MAJ.0b013e3181eecf29     Document Type: Article

References (33)

1. Packard RR, Libby P. Inflammation in atherosclerosis: from vascular biology to biomarker discovery and risk prediction. Clin Chem 2008; 54:24-38.
2. Epstein SE, Zhu J, Najafi AH, et al. Insights into the role of infection in atherogenesis and in plaque rupture. Circulation2009;119:3133-41.
3. Reszka E, Jegier B, Wasowicz W, et al. Detection of infectious agents by polymerase chain reaction in human aortic wall. Cardiovasc Pathol 2008;17:297-302.
4. Saikku P. Seroepidemiology in Chlamydia pneumoniae\atheroscle-rosis association. Eur Heart J 2002;23:263-4.
5. Kuo CC, Shor A, Campbell LA, et al. Demonstration of Chlamydia pneumoniae in atherosclerotic lesions of coronary arteries. J Infect Dis 1993;167:841-9.
6. Oshima T, Ozono R, Yano Y, et al. Association of Helicobacter pylori infection with systemic inflammation and endothelial dysfunction in healthy male subjects. J Am Coll Cardiol 2005;45:1219-22.
7. Chiu B. Multiple infections in carotid atherosclerotic plaques. Am Heart J 1999;138:S534-6.
8. Deshpande RG, Khan MB, Genco CA. Invasion ofaortic and heart endothelial cells by Porphyromonas gingivalis. Infect Immunol 1998; 66:5337-43.
9. Nieto FJ, Adam E, Sorlie P, et al. Cohort study of cytomegalovirus infection as a risk factor for carotid intimal-medial thickening, a measure ofsubclinical atherosclerosis. Circulation 1996;94:922-7.
10. Zhu J, Quyyumi AA, Norman JE, et al. Cytomegalovirus in the patho-genesis ofatherosclerosis: the role of inflammation as reflected by elevated C-reactive protein levels. J Am Coll Cardiol 1999;34:1738-43.
11. Barbaro G, Fisher SD, Giancaspro G, et al. HIV-associated cardio-vascular complications: a new challenge for emergency physicians. Am J Emerg Med 2001;19:566-74.
12. Zhu J, Nieto FJ, Horne BD, et al. Prospective study of pathogen burden and risk of myocardial infarction or death. Circulation 2001; 103:45-51.
13. Zhu J, Quyyumi AA, Norman JE, et al. The possible role of hepatitis A virus in the pathogenesis ofatherosclerosis. J Infect Dis 2000;182: 1583-7.
14. Hall CB. Respiratory syncytial virus and parainfluenza virus. N Engl J Med 2001;344:1917-28.
15. Hart RJ. An outbreak ofrespiratory syncytial virus infection in an old people's home. J Infect 1984;8:259-61.
16. Sorvillo FJ, Huie SF, Strassburg MA, et al. An outbreak ofrespira-tory syncytial virus pneumonia in a nursing home for the elderly. J Infect 1984;9:252-6.
17. Capewell A, Inglis JM, Williamson J. Respiratory syncytial virus infection in the elderly. Br Med J (Clin Res Ed) 1984;288:235-6.
18. Vikerfors T, Grandien M, Olcen P. Respiratory syncytial virus infections in adults. Am Rev Respir Dis 1987;136:561-4.
19. Hall CB, Geiman JM, Biggar R, et al. Respiratory syncytial virus infections within families. N Engl J Med 1976;294:414-9.
20. Johnson KM, Bloom HH, Mufson MA, et al. Natural infection of adults by respiratory syncytial virus: possible relation to mild upper respiratory disease. N Engl J Med 1962;267:68-72.
21. Falsey AR, Cunningham CK, Barker WH, et al. Respiratory syncy-tial virus and influenza A infections in the hospitalized elderly. J Infect Dis 1995;172:389-94.
22. Dowell SF, Anderson LJ, Gary HE Jr, et al. Respiratory syncytial virus is an important cause of community-acquired lower respiratory infection among hospitalized adults. J Infect Dis 1996;174:456-62.
23. Falsey AR, Walsh EE. Respiratory syncytial virus infection in elderly adults. Drugs Aging 2005;22:577-87.
24. Alpert JS, Thygesen K, Antman E, et al. Myocardial infarction redefined: a consensus document of the Joint European Society of Cardiology/American College of Cardiology Committee for the redef-inition ofMyocardial Infarction. J Am Coll Cardiol 2000;36:959-69.
25. Expert Committee on the Diagnosis and Classification of Diabetes Mellitus. Report of the expert committee on the diagnosis and classi-fication ofdiabetes mellitus. Diabetes Care 2003;26:S5-20.
26. Whitworth JA. World Health Organization, International Society of Hypertension Writing Group. 2003 World Health Organization (WHO)/International Society of Hypertension (ISH) statement on management of Hypertension. J Hypertens 2003;21:1983-92.
27. Naghavi M, Wyde P, Litovsky S, et al. Influenza infection exerts prominent inflammatory and thrombotic effects on the atherosclerotic plaques of apolipoprotein E-deficient mice. Circulation 2003;107:762-8.
28. Naghavi M, Barlas Z, Siadaty S, et al. Association of influenza vaccination and reduced risk ofrecurrent myocardial infarction. Circu-lation 2000;102:3039-45.
29. Nichol KL, Nordin J, Mullooly J, et al. Influenza vaccination and reduction in hospitalizations for cardiac disease and stroke among the elderly. N Engl J Med 2003;348:1322-32.
30. Hashem M, Hall CB. Respiratory syncytial virus in healthy adults: the cost of a cold. J Clin Virol 2003;27:14-21.
31. Fong IW. Infections and their role in atherosclerotic vascular disease. J Am Dent Assoc 2002;133 Suppl:7S-13S.
32. Gurfinkel EP, de la Fuente RL, Mendiz O, et al. Influenza vaccine pilot study in acute coronary syndromes and planned percutaneous coronary interventions: the FLU Vaccination Acute Coronary Syn-dromes (FLUVACS) Study. Circulation 2002;105:2143-7.
33. AHA; ACC; National Heart, Lung, Blood Institute; Smith SC Jr, Allen J, Blair SN, et al. AHA/ACC guidelines for secondary preven-tion for patients with coronary and other atherosclerotic vascular disease: 2006 Update: endorsed by the National Heart, Lung, and Blood Institute. J Am Coll Cardiol 2006;47:2130-9.